Neoadjuvant Docetaxel in Breast Cancer: 3-Year Survival Results from the Aberdeen Trial
Tóm tắt
Từ khóa
Tài liệu tham khảo
De Lena, 1978, Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer, Cancer Chemother Pharmacol, 1, 53, 10.1007/BF00253147
Jacquillat, 1990, Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer, Cancer, 66, 119, 10.1002/1097-0142(19900701)66:1<119::AID-CNCR2820660122>3.0.CO;2-3
Hortobagyi, 1988, Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy, Cancer, 62, 2507, 10.1002/1097-0142(19881215)62:12<2507::AID-CNCR2820621210>3.0.CO;2-D
Heys, 1993, Multimodality treatment in the management of locally advanced breast cancer, JR Coll Surg Edinb, 38, 9
Heys, 1994, Role of multimodality therapy in the management of locally advanced carcinoma of the breast, J Am Coll Surg, 179, 493
Bonadonna, 1990, Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimetres or more, J Natl Cancer Inst, 82, 1539, 10.1093/jnci/82.19.1539
Bonnadonna, 1996, Primary chemotherapy in surgically resectable breast cancer, CA Cancer J Clin, 45, 227, 10.3322/canjclin.45.4.227
1998, Polychemotherapy for early breast cancer: an overview of the randomised trials, Lancet, 352, 930, 10.1016/S0140-6736(98)03301-7
van der Hage, 2001, Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902, J Clin Oncol, 19, 4224, 10.1200/JCO.2001.19.22.4224
Mauriac, 1999, Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonie Bordeaux Groupe Sein (IBBGS), Ann Oncol, 10, 47, 10.1023/A:1008337009350
Scholl, 1994, Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumors considered too large for breast conserving surgery: preliminary results of a randomised trial: S6, Eur J Cancer, 30A, 645, 10.1016/0959-8049(94)90537-1
Semiglazov, 1994, Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer, Ann Oncol, 5, 591, 10.1093/oxfordjournals.annonc.a058929
Powles, 1995, Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer, J Clin Oncol, 13, 547, 10.1200/JCO.1995.13.3.547
Wolmark, 2001, Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18, J Natl Cancer Inst Monogr, 30, 96, 10.1093/oxfordjournals.jncimonographs.a003469
Makris, 1998, A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer, Ann Oncol, 9, 1179, 10.1023/A:1008400706949
Nabholtz, 2000, Chemotherapy of breast cancer: are the taxanes going to change the natural history of breast cancer?, Expert Opin Pharmacother, 1, 187, 10.1517/14656566.1.2.187
Doliny, 1999, Phase II trial of neoadjuvant (NEO) docetaxel and cisplatin (DP) for the treatment of locally advanced breast cancer (LABC), Proc Am Soc Clin Oncol, 18, 84a
Dorr, 1999, A pilot multimodality study with preoperative and post-operative chemotherapy with taxotere (docetaxel) and adriamycin (doxorubicin) (TA) for locally advanced breast cancer, Proc Am Soc Clin Oncol, 18, 92a
Laurence, 1999, Phase II study of sequential docetaxel (Taxotere, TXT) and doxorubicin (DOX) as primary chemotherapy (CT) for large operable breast cancer (BC), Proc Am Soc Clin Oncol, 8, 98a
Smith, 2002, Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel, J Clin Oncol, 20, 1456, 10.1200/JCO.20.6.1456
Miller, 1981, Reporting results of cancer treatment, Cancer, 47, 207, 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6
Smith, 2001, Issues involved in research into the neoadjuvant treatment of breast cancer, Anticancer Drugs, 12, S25
Chetty, 2000, Management of the axilla in operable breast cancer treated by breast conservation: a randomised clinical trial, Br J Surg, 87, 163, 10.1046/j.1365-2168.2000.01345.x